Perhaps the mostwell-known mechanism to evade the antitumor immune response is mediated by theinteraction of programmed cell death-ligand 1 (PD-L1), found on tumor and TMEcells, with the cognate receptor, programmed cell death protein 1 (PD-1),expressed on activated T cells. The gene discussed is PDCD1; the disease is neoplasm.